Loading…

Protocol - Electronic Nicotine Product Device Type

Add to My Toolkit
Description

Questions that are asked of people who have ever used any e-product(s)

Specific Instructions

This protocol was systematically updated to reflect the Wave 7 data collection of the Population Assessment of Tobacco and Health (PATH) Study. This protocol will be formally reviewed by a TRR Content Expert Panel early in 2024.

These questions are asked only of people who have ever used e-products, so this must be ascertained before administering these questions.

Availability

Available

Protocol

The next questions are about electronic nicotine products. Some electronic nicotine products can be bought as one-time, disposable products, while others can be bought as re-usable kits with a pod, cartridge, or tank system. Some people refill their own electronic nicotine products with nicotine fluid, sometimes called “e-liquid” or “e-juice”. 

Disposable products, pods, cartridges, and e-liquid come in many different flavors and nicotine concentrations. Some common brands include JUUL, Vuse, Blu, NJOY, eGo, Suorin, Bo, Smok, Phix, and Puff, but there are many others.

Please do not include marijuana or cannabis when answering the following questions about electronic nicotine products.

1. Which of the following kinds of electronic nicotine products [do/did] you use? Choose all that apply. As a reminder, please do not include marijuana or cannabis when answering.

1[ ]E-cigarette including a pod device, vape pen, tank system, or mod

2[ ]E-cigar

3[ ]E-pipe

4[ ]E-hookahincluding a hookah pen

5[ ]Something else (SPECIFY)

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who have ever used an electronic nicotine product.

2. Which kind of electronic nicotine product [do/did] you use most often?

1[ ]E-cigarette including a pod device, vape pen, tank system, or mod

2[ ]E-cigar

3[ ]E-pipe

4[ ]E-hookah including a hookah pen

5[ ]Something else (SPECIFY)

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who selected more than one option during Q1.

3. Which of the following types of electronic nicotine products [do/did] you use? Choose all that apply.

1[ ]A disposable device

2[ ]A device that uses replaceable pods or cartridges

3[ ]A device with a tank that you refill with liquids

4[ ]A mod system

5[ ]Something else (SPECIFY)

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who have ever used an electronic nicotine product.

4. Which type of electronic nicotine products [do/did] you use most often?

1[ ]A disposable device

2[ ]A device that uses replaceable pods or cartridges

3[ ]A device with a tank that you refill with liquids

4[ ]A mod system

5[ ]Something else (SPECIFY)

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who selected more than one option during Q3.

5. When your pod or cartridge is empty, do you usually refill it with e-liquid or replace it with a new prefilled one?

1[ ]Refill it with e-liquid

2[ ]Replace it with a new prefilled one

3[ ]I have never replaced or refilled an empty one

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who selected Q4 = 2.

6. How many milliliters of e-liquid [does/did] your electronic nicotine product hold?

1[ ]|___|___|___|

2[ ]I don’t know

-8[ ]DON’T KNOW

-7[ ]REFUSED

ASK: Respondents who have ever used an electronic nicotine product.

Personnel and Training Required

None

Equipment Needs

None

Requirements
Requirement CategoryRequired
Major equipment No
Specialized training No
Specialized requirements for biospecimen collection No
Average time of greater than 15 minutes in an unaffected individual No
Mode of Administration

Self-administered or interviewer-administered questionnaire

Lifestage

Adolescent, Adult, Senior, Pregnancy

Participants

≥12 years of age

Selection Rationale

The protocol from the Population Assessment of Tobacco and Health (PATH) Study was selected because this study is the most comprehensive study on tobacco use in the civilian, noninstitutionalized population of the United States. The PATH Study is a longitudinal cohort study that includes tobacco product specific use questions and is administered to individuals aged 12 years and older. PATH Wave 7 was selected because it is the most up-to-date version of the PATH Study questionnaire that assesses multiple electronic nicotine delivery systems.

Language

English, Other languages available at source

Standards
StandardNameIDSource
Derived Variables

None

Process and Review

Not applicable.

Protocol Name from Source

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)

Source

National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health.

Final_PATH_Wave_7_English_Adult_Questionnaire.pdf

General References

National Institutes of Health, U.S. Food and Drug Administration. (2023). Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 – December 2022), English Data Collection Instrument. Bethesda, MD: National Institutes of Health. Final_PATH_Wave_7_English_Adult_Questionnaire.pdf

Protocol ID

760102

Variables
Export Variables
Variable Name Variable IDVariable DescriptiondbGaP Mapping
Tobacco Regulatory Research Core: Tier 1
Measure Name

Electronic Device Type

Release Date

December 22, 2023

Definition

Questions to determine type of electronic nicotine product device used.

Purpose

This measure can be utilized to assess the specific electronic nicotine product(s) used.

Keywords

electronic nicotine products, e-cigarettes, tank system, e-liquid, e-juice, cartridges, pod, mod, tank, disposable, e-pipe, e-cigar, e-hookah, vape pen, Population Assessment of Tobacco and Health Study, PATH, National Institute on Drug Abuse, NIDA, Food and Drug Administration, FDA

Measure Protocols
Protocol ID Protocol Name
760102 Electronic Nicotine Product Device Type
Publications

There are no publications listed for this protocol.